A local innate immune response against Trypanosoma cruzi in the human placenta: The epithelial turnover of the trophoblast

Microbial Pathogenesis

Volumn 99, Issue , 2016, Pages 123-129

  Liempi, Ana ^a   Castillo, Christian ^a   Carrillo, Ileana ^a   Muñoz, Lorena ^a   Droguett, Daniel ^a,b   Galanti, Norbel ^a   Maya, Juan Diego ^a   Kemmerling, Ulrike ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE TALCA   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL METABOLISM; CELL PROLIFERATION; CELL SURFACE; CHAGAS DISEASE; FETUS DEVELOPMENT; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; NONHUMAN; PARASITE TRANSMISSION; PLACENTA; PRIORITY JOURNAL; REVIEW; TROPHOBLAST EPITHELIAL TURNOVER; TRYPANOSOMA CRUZI; VERTICAL TRANSMISSION; FEMALE; IMMUNOLOGY; PARASITOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; TROPHOBLAST;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHAGAS DISEASE; FEMALE; HUMANS; IMMUNITY, INNATE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TROPHOBLASTS; TRYPANOSOMA CRUZI;

EID: 84983782733     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.08.022     Document Type: Review

References (57)

1. [1] Altemani, A.M., Bittencourt, A.L., Lana, A.M., Immunohistochemical characterization of the inflammatory infiltrate in placental chagas' disease: a qualitative and quantitative analysis. Am. J. Trop. Med. Hyg. 62:2 (2000), 319–324.
2. [2] Baergen KBPKR, Pathology of the Human Placenta. fifth ed., 2006, Springer Science-Business Media, Inc., 1065.
3. [3] Bern, C., Chagas' disease. N. Engl. J. Med. 373:5 (2015), 456–466.
4. [4] Bern, C., Martin, D.L., Gilman, R.H., Acute and congenital chagas disease. Adv. Parasitol. 75 (2011), 19–47.
5. [5] Bittencourt, A.L., Congenital chagas disease. Am. J. Dis. Child. 130:1 (1976), 97–103.
6. [6] Brutus, L., Castillo, H., Bernal, C., Salas, N.A., Schneider, D., Santalla, J.A., Chippaux, J.P., Detectable trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital chagas disease. Am. J. Trop. Med. Hyg. 83:5 (2010), 1044–1047.
7. [7] Carlier, Y., Sosa-Estani, S., Luquetti, A.O., Buekens, P., Congenital chagas disease: an update. Memorias do Inst. Oswaldo Cruz 110:3 (2015), 363–368.
8. [8] Carlier, Y., Truyens, C., Congenital chagas disease as an ecological model of interactions between trypanosoma cruzi parasites, pregnant women, placenta and fetuses. Acta trop. 151 (2015), 103–115.
9. [9] Carlier, Y., Truyens, C., Deloron, P., Peyron, F., Congenital parasitic infections: a review. Acta trop. 121:2 (2012), 55–70.
10. [10] Carrillo, I., Droguett, D., Castillo, C., Liempi, A., Munoz, L., Maya, J.D., Galanti, N., Kemmerling, U., Caspase-8 activity is part of the bewo trophoblast cell defense mechanisms against trypanosoma cruzi infection. Exp. Parasitol. 168 (2016), 9–15.
11. [11] Castillo, C., Lopez-Munoz, R., Duaso, J., Galanti, N., Jana, F., Ferreira, J., Cabrera, G., Maya, J.D., Kemmerling, U., Role of matrix metalloproteinases 2 and 9 in ex vivo trypanosoma cruzi infection of human placental chorionic villi. Placenta 33:12 (2012), 991–997.
12. [12] Castillo, C., Villarroel, A., Duaso, J., Galanti, N., Cabrera, G., Maya, J.D., Kemmerling, U., Phospholipase c gamma and erk1/2 mitogen activated kinase pathways are differentially modulated by trypanosoma cruzi during tissue invasion in human placenta. Exp. Parasitol. 133:1 (2013), 12–17.
13. [13] Claycombe, K.J., Brissette, C.A., Ghribi, O., Epigenetics of inflammation, maternal infection, and nutrition. J. Nutr. 145:5 (2015), 1109S–1115S.
14. [14] Cliffe, L.J., Humphreys, N.E., Lane, T.E., Potten, C.S., Booth, C., Grencis, R.K., Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 308:5727 (2005), 1463–1465.
15. [15] Corrales, R.M., Mora, M.C., Negrette, O.S., Diosque, P., Lacunza, D., Virreira, M., Breniere, S.F., Basombrio, M.A., Congenital chagas disease involves trypanosoma cruzi sub-lineage iid in the northwestern province of salta, Argentina. Infection, genetics and evolution. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 9:2 (2009), 278–282.
16. [16] Coura, J.R., Chagas disease: what is known and what is needed–a background article. Memorias do Inst. Oswaldo Cruz 102:Suppl 1 (2007), 113–122.
17. [17] de Souza, E.M., Araujo-Jorge, T.C., Bailly, C., Lansiaux, A., Batista, M.M., Oliveira, G.M., Soeiro, M.N., Host and parasite apoptosis following trypanosoma cruzi infection in in vitro and in vivo models. Cell Tissue Res. 314:2 (2003), 223–235.
18. [18] Diaz-Lujan, C., Triquell, M.F., Schijman, A., Paglini, P., Fretes, R.E., Differential susceptibility of isolated human trophoblasts to infection by trypanosoma cruzi. Placenta 33:4 (2012), 264–270.
19. [19] Drewlo, S., Baczyk, D., Dunk, C., Kingdom, J., Fusion assays and models for the trophoblast. Methods Mol. Biol. 475 (2008), 363–382.
20. [20] Duaso, J., Rojo, G., Cabrera, G., Galanti, N., Bosco, C., Maya, J., Morello, A., Kemmerling, U., Trypanosoma cruzi induces tissue disorganization and destruction of chorionic villi in an ex vivo infection model of human placenta. Placenta 31:8 (2010), 705–711.
21. [21] Duaso, J., Rojo, G., Jana, F., Galanti, N., Cabrera, G., Bosco, C., Lopez-Munoz, R., Maya, J.D., Ferreira, J., Kemmerling, U., Trypanosoma cruzi induces apoptosis in ex vivo infected human chorionic villi. Placenta 32:5 (2011), 356–361.
22. [22] Duaso, J., Yanez, E., Castillo, C., Galanti, N., Cabrera, G., Corral, G., Maya, J.D., Zulantay, I., Apt, W., Kemmerling, U., Reorganization of extracellular matrix in placentas from women with asymptomatic chagas disease: mechanism of parasite invasion or local placental defense?. J. Trop. Med., 2012, 2012, 758357.
23. [23] Forbes, K., Westwood, M., Maternal growth factor regulation of human placental development and fetal growth. J. Endocrinol. 207:1 (2010), 1–16.
24. [24] Gauster, M., Huppertz, B., The paradox of caspase 8 in human villous trophoblast fusion. Placenta 31:2 (2010), 82–88.
25. [25] Gauster, M., Moser, G., Orendi, K., Huppertz, B., Factors involved in regulating trophoblast fusion: potential role in the development of preeclampsia. Placenta 30:Suppl A (2009), S49–S54.
26. [26] Gauster, M., Siwetz, M., Huppertz, B., Fusion of villous trophoblast can be visualized by localizing active caspase 8. Placenta 30:6 (2009), 547–550.
27. [27] Hasnain, S.E., Begum, R., Ramaiah, K.V., Sahdev, S., Shajil, E.M., Taneja, T.K., Mohan, M., Athar, M., Sah, N.K., Krishnaveni, M., Host-pathogen interactions during apoptosis. J. Biosci. 28:3 (2003), 349–358.
28. [28] Hazlett, L., Wu, M., Defensins in innate immunity. Cell tissue Res. 343:1 (2011), 175–188.
29. [29] Hermann, E., Berthe, A., Truyens, C., Alonso-Vega, C., Parrado, R., Torrico, F., Carlier, Y., Braud, V.M., Killer cell immunoglobulin-like receptor expression induction on neonatal cd8(+) t cells in vitro and following congenital infection with trypanosoma cruzi. Immunology 129:3 (2010), 418–426.
30. [30] Howard, E.J., Xiong, X., Carlier, Y., Sosa-Estani, S., Buekens, P., Frequency of the congenital transmission of trypanosoma cruzi: a systematic review and meta-analysis. BJOG: Int. J. Obstetrics Gynaecol. 121:1 (2014), 22–33.
31. [31] Huppertz, B., Borges, M., Placenta trophoblast fusion. Methods Mol. Biol. 475 (2008), 135–147.
32. [32] Huppertz, B., Gauster, M., Trophoblast fusion. Adv. Exp. Med. Biol. 713 (2011), 81–95.
33. [33] Janeway, C.A. Jr., Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 20 (2002), 197–216.
34. [34] Juiz, N.A., Cayo, N.M., Burgos, M., Salvo, M.E., Nasser, J.R., Bua, J., Longhi, S.A., Schijman, A.G., Human polymorphisms in placentally expressed genes and their association with susceptibility to congenital trypanosoma cruzi infection. J. Infect. Dis. 213:8 (2016), 1299–1306.
35. [35] Kemmerling, U., Bosco, C., Galanti, N., Infection and invasion mechanisms of trypanosoma cruzi in the congenital transmission of chagas' disease: a proposal. Biol. Res. 43:3 (2010), 307–316.
36. [36] Kim, M., Ashida, H., Ogawa, M., Yoshikawa, Y., Mimuro, H., Sasakawa, C., Bacterial interactions with the host epithelium. Cell Host Microbe 8:1 (2010), 20–35.
37. [37] Koga, K., Aldo, P.B., Mor, G., Toll-like receptors and pregnancy: trophoblast as modulators of the immune response. J. Obstetrics Gynaecol. Res. 35:2 (2009), 191–202.
38. [38] Liempi, A., Castillo, C., Cerda, M., Droguett, D., Duaso, J., Barahona, K., Hernandez, A., Diaz-Lujan, C., Fretes, R., Hartel, S., et al. Trypanosoma cruzi infectivity assessment in “in vitro” culture systems by automated cell counting. Acta Trop. 143 (2015), 47–50.
39. [39] Liempi, A., Castillo, C., Duaso, J., Droguett, D., Sandoval, A., Barahona, K., Hernandez, A., Galanti, N., Maya, J.D., Kemmerling, U., Trypanosoma cruzi induces trophoblast differentiation: a potential local antiparasitic mechanism of the human placenta?. Placenta, 2014.
40. [40] Lujan, C.D., Triquell, M.F., Sembaj, A., Guerrero, C.E., Fretes, R.E., Trypanosoma cruzi: productive infection is not allowed by chorionic villous explant from normal human placenta in vitro. Exp. Parasitol. 108:3–4 (2004), 176–181.
41. [41] Mayhew, T.M., Turnover of human villous trophoblast in normal pregnancy: what do we know and what do we need to know?. Placenta 35:4 (2014), 229–240.
42. [42] Mor, G., Cardenas, I., The immune system in pregnancy: a unique complexity. Am. J. Reproductive Immunol. 63:6 (2010), 425–433.
43. [43] Moretti, E., Basso, B., Castro, I., Carrizo Paez, M., Chaul, M., Barbieri, G., Canal Feijoo, D., Sartori, M.J., Carrizo Paez, R., Chagas' disease: study of congenital transmission in cases of acute maternal infection. Rev. Soc. Bras. Med. Trop. 38:1 (2005), 53–55.
44. [44] Mysorekar, I.U., Mulvey, M.A., Hultgren, S.J., Gordon, J.I., Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic escherichia coli. J. Biol. Chem. 277:9 (2002), 7412–7419.
45. [45] Ortiz, S., Zulantay, I., Solari, A., Bisio, M., Schijman, A., Carlier, Y., Apt, W., Presence of trypanosoma cruzi in pregnant women and typing of lineages in congenital cases. Acta Trop. 124:3 (2012), 243–246.
46. [46] Perez-Molina, J.A., Perez, A.M., Norman, F.F., Monge-Maillo, B., Lopez-Velez, R., Old and new challenges in chagas disease. Lancet Infect. Dis. 15:11 (2015), 1347–1356.
47. [47] Pidoux, G., Gerbaud, P., Cocquebert, M., Segond, N., Badet, J., Fournier, T., Guibourdenche, J., Evain-Brion, D., Review: human trophoblast fusion and differentiation: lessons from trisomy 21 placenta. Placenta 33:Suppl (2012), S81–S86.
48. [48] Racicot, K., Kwon, J.Y., Aldo, P., Abrahams, V., El-Guindy, A., Romero, R., Mor, G., Type i interferon regulates the placental inflammatory response to bacteria and is targeted by virus: mechanism of polymicrobial infection-induced preterm birth. Am. J. Reproductive Immunol. 75:4 (2016), 451–460.
49. [49] Rassi, A. Jr., Rassi, A., Marcondes de Rezende, J., American trypanosomiasis (chagas disease). Infect. Dis. Clin. N. Am. 26:2 (2012), 275–291.
50. [50] Rendell, V.R., Gilman, R.H., Valencia, E., Galdos-Cardenas, G., Verastegui, M., Sanchez, L., Acosta, J., Sanchez, G., Ferrufino, L., LaFuente, C., et al. Trypanosoma cruzi-infected pregnant women without vector exposure have higher parasitemia levels: implications for congenital transmission risk. PLoS one, 10(3), 2015, e0119527.
51. [51] Savage, D.C., Siegel, J.E., Snellen, J.E., Whitt, D.D., Transit time of epithelial cells in the small intestines of germfree mice and ex-germfree mice associated with indigenous microorganisms. Appl. Environ. Microbiol. 42:6 (1981), 996–1001.
52. [52] Schmunis, G., Epidemiology of chagas disease in non-endemic countries: the role of international migration. Mem. Inst. Oswaldo Cruz 102:Suppl 1 (2007), 75–85.
53. [53] Shippey, S.H. 3rd, Zahn, C.M., Cisar, M.M., Wu, T.J., Satin, A.J., Use of the placental perfusion model to evaluate transplacental passage of trypanosoma cruzi. Am. J. Obstetrics Gynecol. 192:2 (2005), 586–591.
54. [54] Telleria, J., Biron, D.G., Brizard, J.P., Demettre, E., Seveno, M., Barnabe, C., Ayala, F.J., Tibayrenc, M., Phylogenetic character mapping of proteomic diversity shows high correlation with subspecific phylogenetic diversity in trypanosoma cruzi. Proc. Natl. Acad. Sci. U. S. A. 107:47 (2010), 20411–20416.
55. [55] Wang, S.C., Pcna: a silent housekeeper or a potential therapeutic target?. Trends Pharmacol. Sci. 35:4 (2014), 178–186.
56. [56] WHO, Chagas disease in latin America: an epidemiological update based on 2010 estimates. Wkly. Epidemiol. Rec. 90:6 (2015), 33–43.
57. [57] Zingales, B., Miles, M.A., Campbell, D.A., Tibayrenc, M., Macedo, A.M., Teixeira, M.M., Schijman, A.G., Llewellyn, M.S., Lages-Silva, E., Machado, C.R., et al. The revised trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. Infection, genetics and evolution. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 12:2 (2012), 240–253.